ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ROH Rohm & Haas

0.00
0.00 (0.00%)
After Hours
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Rohm & Haas NYSE:ROH NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Dow Chemical Files Motion To Disqualify Rohm & Haas Lawyers

05/02/2009 4:42pm

Dow Jones News


Rohm Haas (NYSE:ROH)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Rohm Haas Charts.

Dow Chemical Co. (DOW) filed a motion late Wednesday to disqualify Rohm & Haas Co.'s (ROH) law firm Wachtell, Lipton, Rosen and Katz from conducting discovery against Dow and examining Dow's witnesses.

Rohm has sued Dow in Delaware Chancery Court to force the completion of Dow's $15.3 billion deal to purchase Rohm, which had been set to close late last month.

Dow said it sought the disqualification from those proceedings because of Wachtell's representation of it in some other matters directly related to the current litigation. The company said it does not seek a blanket disqualification of Wachtell from the case.

A Rohm spokeswoman said Thursday Dow Chemical's motion was a "litigation tactic that has no merit."

Meanwhile, a judge Thursday denied Dow's application to delay the start of a trial on a specific plan for the merger agreement. The trial is due to start March 9 after the Delaware court late last month agreed to handle the case on an expedited basis at Rohm's request, according to the Delaware Law Weekly.

Dow Chemical, the world's third-largest chemicals group by revenue, said earlier this week it could face multiple debt defaults if forced to consummate its proposed acquisition of Rohm before it has stable financing.

Meanwhile, a $1.55 billion fourth-quarter loss highlights the company's continuing exposure to the weakening commodity-chemicals business. That is why it was seeking to spin its basic-chemicals operations into a now-failed joint venture with Kuwait and buy Rohm & Haas, which would get Dow Chemical into higher-margin segments.

Earlier Thursday, hedge fund Paulson & Co. urged Dow Chemical to complete the buyout, saying it could cut its dividend to a nominal 1 cent a share from 42 cents and sell common stock and bonds to pay off the $13 billion in bridge financing needed to complete the deal. Paulson is Rohm & Haas's second-largest shareholder.

Dow's shares were recently down 1.6% at $10.60 and Rohm's were up 1.5% at $54.55.

-By Kerry E. Grace, Dow Jones Newswires; 201-938-5089; kerry.grace@dowjones.com

 
 

1 Year Rohm Haas Chart

1 Year Rohm Haas Chart

1 Month Rohm Haas Chart

1 Month Rohm Haas Chart